AMNEAL PHARMACEUTICALS, INC. (AMRX) Gross margin 2016–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) gross margin by fiscal year — reported gross profit divided by reported revenue.
36.9%FY2025 · since FY2016: 58.7% → 36.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 36.9% | +0.4 pp |
| FY2024 | 36.5% | +2.2 pp |
| FY2023 | 34.3% | -1.2 pp |
| FY2022 | 35.5% | -1.3 pp |
| FY2021 | 36.7% | +5.2 pp |
| FY2020 | 31.5% | +9.8 pp |
| FY2019 | 21.7% | -21.4 pp |
| FY2018 | 43.1% | -7.8 pp |
| FY2017 | 50.9% | -7.8 pp |
| FY2016 | 58.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice